摘要
目的 对比性研究Ⅷ因子相关抗原 (factorⅧ relatedantigen ,FⅧ RAg)、CD31、CD34在显示肺癌组织微血管密度 (microvesseldensity,MVD)中的差异 ,以及MVD与生存期的关系。 方法 采用免疫组织化学技术 ,以FⅧ RAg、抗CD31抗体、抗CD34抗体对 5 3例手术切除、石蜡包埋肺癌组织中的微血管内皮细胞进行染色。 结果 FⅧ RAg、CD31、CD34阳性率均为 10 0 % ,MVD分别为 (2 0 .4 1± 9.6 2 )条 /HP、(2 1.84± 13.2 4 )条 /HP和 (2 1.96± 11.6 7)条/HP ,3者之间差异无统计学意义 (P >0 .0 5 ) ;血管高密度组的生存时间均明显较血管低密度组的生存时间短 (P <0 .0 5 ,P <0 .0 0 1,P <0 .0 0 0 1)。结论 提示CD34是显示肺癌组织MVD的合适的标记物 ;
Objective To evaluate the differences among three most commonly used endothelial markers for microvessel density(MVD),factor Ⅷ-related antigen(FⅧ-RAg),CD31,CD34 in lung cancer,and the relation of MVD to the survival.Methods The study consisted of 53 patients with lung carcinoma surgery.Immunohistochemistry on paraffin sections was performed with FⅧ-RAg,anti-CD31 antibody and anti-CD34 antibody to study MVD.Results The positive rates of FⅧ-RAg,CD31 and CD34 were all 100%. And their average counts of MVD were ( 20.41± 9.62),( 21.84± 13.24) and ( 21.96± 11.67)pieces/HP.MVD shown by FⅧ-RAg,CD31 and CD34 had no significant differences(P> 0.05).The survival rate of patiants with high MVD was lower than that of patiants with low MVD(P< 0.05,P< 0.001,P< 0.0001).Conclusion CD34 is a suitable marker for the immunohistochemical visualization of MVD in lung cancer.MVD is a good prognostic factor for patients with lung cancer.
出处
《临床荟萃》
CAS
北大核心
2004年第18期1021-1023,共3页
Clinical Focus
关键词
肺肿瘤
微血管密度
免疫组织化学
lung heoplasms
microvessel density
immunohistochemistry